東寶生物(300239.SZ):擬聘請信永中和會計師事務所
格隆匯11月30日丨東寶生物(300239.SZ)公佈,大華會計師事務所(特殊普通合夥)(“大華”)已連續9年為公司提供審計服務,期間未進行輪換。因公司控股股東發生變更,根據公司業務現狀及發展需要,在統籌年度審計工作的基礎上,經公司綜合評估,擬聘請信永中和會計師事務所(特殊普通合夥)(“信永中和”)為公司2021年度財務審計機構。公司已事先與大華、信永中和進行了充分溝通,各方均已確認對本次擬變更會計師事務所的事項無異議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.